| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |